Many people don’t know much about Urofollitropin, its main treatment for
infertility, let’s learn about it with Kang Yuan’s editor below!
Urofollitropin is used in anovulatory patients (including polycystic ovary
syndrome) who do not respond to clomiphene citrate treatment.
The goal of urofollitropin treatment is to generate a single mature Graff
follicle and then use HCG to induce egg release.
Urofollitropin can be injected daily in a course of treatment, and in
menstruating patients, treatment should begin within the first seven days of the
menstrual cycle.
The treatment regimen should be adjusted according to the patient's
response. The usual treatment regimen starts with daily injections of FSH up to
75 units-150 units, if necessary, increases or decreases by 75 units daily at 7
or 14-day intervals to obtain a modest (not excessive) response, if after 4
weeks If the treatment response is still poor, the treatment in this cycle
should be stopped.
If the reaction is moderate, 24-48 hours after the last injection of this
product, a single intramuscular dose of 10,000 units of HCG should be
administered, and the patient should be advised to have sex on the day or the
next day.
If the response is excessive, treatment should be discontinued and HCG
discontinued, and a lower dose of the previous cycle should be used in the next
cycle.
The above is the relevant content summarized by the editor of Kangyuan
Company. If you want to know more, please continue to follow us. We will
regularly update you about Human chorionic gonadotropin, Human Menopausal
Gonadotropin supplier, Urofollitropin price, Urokinase manufacturer, and Hormone
API Manufacturer Related content, I hope to help you.